Navigation Links
Allos Therapeutics Reports Third Quarter 2007 Financial Results
Date:11/5/2007

14,503

Restructuring and

separation costs - - 646 -

Total operating

expenses 8,591 10,142 23,614 30,586

Loss from operations (8,591) (10,142) (23,614) (30,586)

Interest and other income,

net 480 844 1,471 2,526

Net loss $(8,111) $(9,298) $(22,143) $(28,060)

Net loss per share: basic and

diluted $(0.15) $(0.14) $(0.40) $(0.43)

Weighted average shares

outstanding:

basic and diluted 55,196,369 66,042,023 55,126,488 64,627,285

ALLOS THERAPEUTICS, INC.

CONDENSED BALANCE SHEETS

(in thousands)

(unaudited)

December 31, September 30,

2006 2007

ASSETS

Cash, cash equivalents and

investments in marketable

securities $32,796 $63,370

Other assets 2,982 3,525

Property and equipment, net 604 543

Total assets $36,382 $67,438

LIABILITIES AND STOCKHOLDERS' EQUITY

Liabilities $6,832 $8,170

Stockholders' equity 29,550 59,268

Total liabilities and

stockholders' equity $36,382 $67,438


'/>"/>
SOURCE Allos Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference
2. Prime Therapeutics Receives TIPPS Certification
3. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
4. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
5. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
6. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
7. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
8. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
9. Prime Therapeutics Announces URAC Accreditation
10. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
11. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...- Inc. Magazine recently included,Connolly Consult...ing,private companies in the country. The list is ...segment of the economy -- America,s,independent-mi...ies,represent the backbone of the U.S. economy., ...03/NY36880LOGO ), Connolly Consulting,s consiste...
(Date:10/3/2008)... Discrimination; Recognizes,Importance of Mental H.../PRNewswire-USNewswire/ -- Mental Health,America t...approval of a,mental health parity legislation tha...ion against Americans with mental health and subst...lans., The legislation, which recognizes the impo...
(Date:10/3/2008)...search Foundation(R) Collection of, Bouquets to T...Research, LOS ANGELES, Oct. 3 /PRNewswire/ -- Tel...g only hand-arranged, hand-delivered floral,arrang...nth-long,collaboration with The City of Hope, John... Cancer Center in southern California and national...
(Date:10/3/2008)...- As the population ages, a big,question employers...e the,financial crunch of an illness?", In most c...eck to,paycheck and now need two incomes to provid... spouses becomes critically ill and unable to work...ut the healthy,employee/spouse is strained by the ...
Breaking Medicine News(10 mins):Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 2Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 3Health News:Can Your Employees Survive the Financial Crunch of an Illness? 2
...nd to be effective in reducing chest pain, not ass...f patients with chest pain have no identifiable ca...e efforts by cardiologists, they continue to be se...icularly, young women seem be more prone to this c...
...that was conducted by the London School of Hygiene... pandemic across Europe, it was found that serious...tween countries existed. // The Czech Republic, It...gal were the least prepared. It is necessary that...
...d the largest outbreak of mumps over the past two ... country since 1988 // , is believed to have begun... federal officials reported yesterday that the out...ng to latest information from the U.S. Centres for...
...Queen's University and the University of Pennsylva... for drugs like Celebrex and Vioxx, administered f...otential risk of triggering a heart problem Co-aut...istry and Physiology at Queen's, and Canada Resear...
Other Medicine News:Health News:Non-Cardiac Chest Pain Can Be Treated By Hypnotherapy 2Health News:Joint Effort among Various Nations to Tackle Bird Flu 2Health News:Mumps Outbreak In The US 2Health News:Mumps Outbreak In The US 3
(Date:10/6/2008)...oncept of Other Product - Company,s Bioabsorbable ... HONG KONG, Oct. 6 /- Data from mult...ing stent, OrbusNeich,s Genous Bio-engineered R,st...ter Cardiovascular,Therapeutics symposium, TCT 200...Ph.D., of the Academic Medical Center in,Amsterdam...
(Date:10/5/2008)... published in New England Journal of Medicine reaf...y profile of SPIRIVA(R),HandiHaler(R), RIDGEFIELD...lts of the,UPLIFT (Understanding Potential Long-te...wed that SPIRIVA(R) HandiHaler(R) (tiotropium brom...lung function for up to 4,years as measured by FEV...
(Date:10/3/2008)...AM, October 3 /- Amsterdam ...n the field of human gene therapy,announced today...to the,Marketing Authorization Application (MAA) f...PLD), a seriously debilitating and potentially let...hase II clinical studies (22,patients in total) de...
(Date:10/3/2008)...nies to Study B-Raf Kinase Inhibitors for Cancer T... Oct. 3 /-,Eli Lilly and Co...harmaceuticals, LLC today announced that the two c...ldwide licensing agreement related to,Deciphera,s ... study of,potential oncology therapeutics., The c...
Breaking Medicine Technology:Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 3Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 2Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 3Support for Patient Navigation Services to Help Cancer Patients 17607 1Support for Patient Navigation Services to Help Cancer Patients 17607 2Oberthur Technologies XPon Offer 3032 1Oberthur Technologies XPon Offer 3032 2Nanotubes grown straight in large numbers 4824 1Nanotubes grown straight in large numbers 4824 2Nanotubes grown straight in large numbers 4824 3President Recognizes Sharp HealthCare With 2007 Malcolm Baldrige National Quality Award at White House 17601 1President Recognizes Sharp HealthCare With 2007 Malcolm Baldrige National Quality Award at White House 17601 2
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: